Cancer startup Cleave raises 10m

 

Apr 9, 2013, 8:20am PDT

Cancer drug startup Cleave Biosciences raises $10M

Enlarge

Cancer drug startup Cleave Biosciences, led by CEO Laura Shawver, has raised $10 million.

	Sponsored Links
	Office VoIP Phone Systems Get unlimited calling and faxing. Easy set-up. No contracts required. www.ringcentral.com/office
	Refinance Today 2.6% APR No costs & no fees! $225K Mortgage for $889mo. Get your free quote. www.LendGo.com
Get Listed Here

Staff Silicon Valley Business Journal

Cleave Biosciences extended its Series A funding by $10 million, the company said Tuesday, by bringing on New Enterprise Associates.
The Burlingame company led by CEO Laura Shawver is working to zero in on discovering small molecules against an anti-cancer target called p97.
NEA joins previous investors US Venture Partners, 5AM Ventures, Clarus Ventures, OrbiMed Advisors, Astellas Venture Management and Osage University Partners.
Click here to read more of this story from the San Francisco Business Times.
Click here to subscribe to TechFlash Silicon Valley, the daily email newsletter about startups, venture and angel investors.

Related links:

Burlingame, Menlo Park, Mountain View, Venture capital, Startups

Industries:

Technology, Health Care